Apidel develops pharmaceutical products and provides innovative and more effective drug delivery solutions.

Our patented technologies
ApidSOL™
ApidSOL™ is an aqueous micelle formulation capable of solubilizing poorly soluble drugs. ApidSOL™ is well tolerated and increases tissue penetration following application on the skin, …
ApidCOR™
ApidCOR™ is a sustained release drug delivery system. ApidCOR™ a homogenous liquid polymer that can readily be injected. Following a single injection, the tailored duration of activity extends over days, weeks or months.

Partnering
Apidel welcomes the opportunity to partner with large and small companies in the pharmaceutical and biotechnology fields to bring the benefits of its drug delivery technology together with particular compounds or to address particular therapeutic or market needs.
Latest News
May 30, 2018
Apidel has received a granted patent from the USPTO
Apidel SA has the pleasure to announce that the patent application entitled "POLYLACTIDE COMPOSITIONS AND USES THEREOF" has been granted in the USA with the following patent number: US 9,925,267 B2.
May 16, 2018
Apidel at Advanced Functional Polymers for Medecine (AFMP) congress in Montpellier
Prof Robert Gurny, CSO and co-founder of Apidel is presenting ApidSOL™ micellar technology for improved local delivery at the Advanced Functional Polymers for Medecine (AFMP) congress at the University of Montpellier, France on May 16-18…
March 21, 2018
ApidSOL™ technology featured at the 11th World Meeting on the Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.
Dr Naoual Dahmana is presenting the results of the project featuring ApidSOL™ technology at the 11th World Meeting on the Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology on March 21 in Granada, Spain. Project title: “Topical…